{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T07:40:24Z","timestamp":1741678824646,"version":"3.38.0"},"reference-count":110,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Womens Health (Lond Engl)"],"published-print":{"date-parts":[[2012,11]]},"abstract":"<jats:p> The incidence of pregnancies affected with neural tube defects (NTDs) has been reduced by food fortification programs and public health campaigns promoting folic acid supplementation, but the incidence of NTDs in the USA has not achieved the full potential reduction expected with adequate periconceptional folate utilization. In seeking new ways to access sexually active women at risk for pregnancy, one option would be to link folic acid supplementation to contraceptive use. Since birth control pills are the most popular method of reversible contraception in the USA, it would seem quite logical to find a way to supplement them. To this end, a very efficient folate, levomefolate calcium salt (metafolin), has been added to drospirenone-containing oral contraceptives in equimolar concentrations to the recommended supplements of folic acid to reduce the risk for pregnancy and to reduce the risk of NTDs in pregnancies that occur while women are taking the pill or shortly after they discontinue its use. This article will focus on the need for such folate supplementation and will summarize the contraceptive and noncontraceptive benefits of the 30 \u03bcg EE\/3 mg drospirenone pill (Yasmin\u00ae, Bayer Healthcare, NJ, USA) to which has been added 451 metafolin (Safyral\u00ae, Bayer Healthcare). The new information about thromboembolism risks associated with use of drospirenone-containing pills is also discussed. <\/jats:p>","DOI":"10.2217\/whe.12.50","type":"journal-article","created":{"date-parts":[[2012,11,26]],"date-time":"2012-11-26T14:34:27Z","timestamp":1353940467000},"page":"619-633","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive Evaluation of Safyral\u00ae 2012"],"prefix":"10.1177","volume":"8","author":[{"given":"Anita L","family":"Nelson","sequence":"first","affiliation":[{"name":"1000 W. Carson Street, Torrance, CA 90509, USA, Tel.: +1 310 937 7226, Fax: +1 310 937 1416,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2012,11,1]]},"reference":[{"unstructured":"Papers of special note have been highlighted as:","key":"bibr1-WHE.12.50"},{"unstructured":"of interest.","key":"bibr2-WHE.12.50"},{"unstructured":"of considerable interest","key":"bibr3-WHE.12.50"},{"doi-asserted-by":"publisher","key":"bibr4-WHE.12.50","DOI":"10.1016\/j.contraception.2011.07.013"},{"doi-asserted-by":"publisher","key":"bibr5-WHE.12.50","DOI":"10.1016\/j.contraception.2011.01.021"},{"doi-asserted-by":"publisher","key":"bibr6-WHE.12.50","DOI":"10.1016\/S0002-9378(98)70047-X"},{"doi-asserted-by":"publisher","key":"bibr7-WHE.12.50","DOI":"10.1016\/j.contraception.2009.06.005"},{"doi-asserted-by":"publisher","key":"bibr8-WHE.12.50","DOI":"10.1111\/j.1471-0528.2012.03321.x"},{"doi-asserted-by":"publisher","key":"bibr9-WHE.12.50","DOI":"10.1093\/ajcn\/63.4.520"},{"doi-asserted-by":"publisher","key":"bibr10-WHE.12.50","DOI":"10.1055\/s-0031-1280855"},{"doi-asserted-by":"publisher","key":"bibr11-WHE.12.50","DOI":"10.1097\/AOG.0b013e3181875ec5"},{"doi-asserted-by":"publisher","key":"bibr12-WHE.12.50","DOI":"10.1016\/j.contraception.2011.04.011"},{"doi-asserted-by":"publisher","key":"bibr13-WHE.12.50","DOI":"10.7326\/0003-4819-150-9-200905050-00009"},{"issue":"1","key":"bibr14-WHE.12.50","first-page":"5","volume":"57","author":"Centers for Disease Control and Prevention (CDC).","year":"2008","journal-title":"MMWR Morb. Mortal. Wkly Rep"},{"issue":"1","key":"bibr15-WHE.12.50","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0020-7292(03)00390-4","volume":"83","author":"Cheschier N","year":"2003","journal-title":"Int. J. Gynaecol. Obstet"},{"doi-asserted-by":"publisher","key":"bibr16-WHE.12.50","DOI":"10.1093\/ajcn\/79.3.473"},{"doi-asserted-by":"publisher","key":"bibr17-WHE.12.50","DOI":"10.2165\/11532990-000000000-00000"},{"key":"bibr18-WHE.12.50","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/13625181003775146","volume":"15","author":"Diefenbach K","year":"2010","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"volume-title":"Special Report: Prevention of Neural Tube Defects for Periconceptional Folic Acid Supplementation in Europe","year":"2009","author":"European Surveillance of Congenital Anomalies.","key":"bibr19-WHE.12.50"},{"doi-asserted-by":"publisher","key":"bibr20-WHE.12.50","DOI":"10.1093\/ajcn\/77.3.658"},{"doi-asserted-by":"publisher","key":"bibr21-WHE.12.50","DOI":"10.1097\/AOG.0b013e3181b46f54"},{"doi-asserted-by":"publisher","key":"bibr22-WHE.12.50","DOI":"10.1016\/j.fertnstert.2009.01.003"},{"doi-asserted-by":"publisher","key":"bibr23-WHE.12.50","DOI":"10.1017\/S1368980008002565"},{"doi-asserted-by":"publisher","key":"bibr24-WHE.12.50","DOI":"10.1016\/j.amepre.2008.09.017"},{"unstructured":"Excellent summary of the discovery of folic acid use to reduce neural tube defects.","key":"bibr25-WHE.12.50"},{"doi-asserted-by":"publisher","key":"bibr26-WHE.12.50","DOI":"10.1016\/j.amepre.2008.07.008"},{"doi-asserted-by":"publisher","key":"bibr27-WHE.12.50","DOI":"10.1007\/s00431-011-1492-8"},{"doi-asserted-by":"publisher","key":"bibr28-WHE.12.50","DOI":"10.1111\/j.1442-2042.2008.02163.x"},{"doi-asserted-by":"publisher","key":"bibr29-WHE.12.50","DOI":"10.1056\/NEJM199911113412006"},{"issue":"31","key":"bibr30-WHE.12.50","first-page":"980","volume":"59","author":"Centers for Disease Control and Prevention (CDC).","year":"2010","journal-title":"MMWR Morb. Mortal. Wkly Rep"},{"doi-asserted-by":"publisher","key":"bibr31-WHE.12.50","DOI":"10.1136\/adc.51.12.944"},{"doi-asserted-by":"publisher","key":"bibr32-WHE.12.50","DOI":"10.1016\/S0140-6736(80)90886-7"},{"doi-asserted-by":"publisher","key":"bibr33-WHE.12.50","DOI":"10.1016\/0140-6736(91)90133-A"},{"doi-asserted-by":"publisher","key":"bibr34-WHE.12.50","DOI":"10.1136\/bmj.282.6275.1509"},{"doi-asserted-by":"publisher","key":"bibr35-WHE.12.50","DOI":"10.1001\/jama.1988.03410210053035"},{"doi-asserted-by":"publisher","key":"bibr36-WHE.12.50","DOI":"10.1001\/jama.1989.03430200091032"},{"doi-asserted-by":"publisher","key":"bibr37-WHE.12.50","DOI":"10.1002\/pd.1970100303"},{"doi-asserted-by":"publisher","key":"bibr38-WHE.12.50","DOI":"10.1097\/00001648-199505000-00005"},{"doi-asserted-by":"publisher","key":"bibr39-WHE.12.50","DOI":"10.1056\/NEJM199911113412001"},{"doi-asserted-by":"publisher","key":"bibr40-WHE.12.50","DOI":"10.7326\/0003-4819-150-9-200905050-00010"},{"doi-asserted-by":"publisher","key":"bibr41-WHE.12.50","DOI":"10.1016\/S0140-6736(06)68917-4"},{"doi-asserted-by":"publisher","key":"bibr42-WHE.12.50","DOI":"10.1093\/ajcn\/85.1.285S"},{"doi-asserted-by":"publisher","key":"bibr43-WHE.12.50","DOI":"10.1001\/jama.1995.03530210052030"},{"unstructured":"Classic work that established the therapeutic levels of folates needed to reduce neural tube defects.","key":"bibr44-WHE.12.50"},{"doi-asserted-by":"publisher","key":"bibr45-WHE.12.50","DOI":"10.1093\/ije\/dyq028"},{"doi-asserted-by":"publisher","key":"bibr46-WHE.12.50","DOI":"10.1136\/bmj.b481"},{"doi-asserted-by":"publisher","key":"bibr47-WHE.12.50","DOI":"10.1007\/s00228-007-0446-6"},{"doi-asserted-by":"publisher","key":"bibr48-WHE.12.50","DOI":"10.1177\/15648265100311S103"},{"doi-asserted-by":"publisher","key":"bibr49-WHE.12.50","DOI":"10.3109\/14767051003678234"},{"doi-asserted-by":"publisher","key":"bibr50-WHE.12.50","DOI":"10.1093\/ajcn\/86.3.718"},{"issue":"17","key":"bibr51-WHE.12.50","first-page":"362","volume":"53","author":"Centers for Disease Control and Prevention (CDC).","year":"1999","journal-title":"MMWR Morb. Mortal. Wkly Rep"},{"issue":"51","key":"bibr52-WHE.12.50","first-page":"1377","volume":"55","author":"Centers for Disease Control and Prevention (CDC).","year":"2007","journal-title":"MMWR Morb. Mortal. Wkly Rep"},{"doi-asserted-by":"publisher","key":"bibr53-WHE.12.50","DOI":"10.2105\/AJPH.85.5.667"},{"doi-asserted-by":"publisher","key":"bibr54-WHE.12.50","DOI":"10.1007\/s10995-006-0104-0"},{"doi-asserted-by":"publisher","key":"bibr55-WHE.12.50","DOI":"10.1093\/aje\/kwm283"},{"doi-asserted-by":"publisher","key":"bibr56-WHE.12.50","DOI":"10.1080\/07315724.2001.10719024"},{"doi-asserted-by":"publisher","key":"bibr57-WHE.12.50","DOI":"10.1016\/j.jada.2008.09.007"},{"doi-asserted-by":"publisher","key":"bibr58-WHE.12.50","DOI":"10.1093\/ajcn\/88.2.348"},{"doi-asserted-by":"publisher","key":"bibr59-WHE.12.50","DOI":"10.1016\/j.jada.2008.05.004"},{"doi-asserted-by":"publisher","key":"bibr60-WHE.12.50","DOI":"10.1016\/j.reprotox.2005.03.009"},{"doi-asserted-by":"publisher","key":"bibr61-WHE.12.50","DOI":"10.1007\/s10654-004-2253-z"},{"doi-asserted-by":"publisher","key":"bibr62-WHE.12.50","DOI":"10.1007\/s10995-010-0587-6"},{"doi-asserted-by":"publisher","key":"bibr63-WHE.12.50","DOI":"10.1210\/jc.2003-031158"},{"doi-asserted-by":"publisher","key":"bibr64-WHE.12.50","DOI":"10.1016\/S0010-7824(00)00133-5"},{"doi-asserted-by":"publisher","key":"bibr65-WHE.12.50","DOI":"10.1016\/S0010-7824(96)00195-3"},{"doi-asserted-by":"publisher","key":"bibr66-WHE.12.50","DOI":"10.1016\/0022-4731(83)90010-9"},{"issue":"6","key":"bibr67-WHE.12.50","first-page":"1816","volume":"80","author":"Oelkers W","year":"1995","journal-title":"J. Clin. Endocrinol. Metab"},{"doi-asserted-by":"publisher","key":"bibr68-WHE.12.50","DOI":"10.1016\/j.contraception.2011.05.015"},{"doi-asserted-by":"publisher","key":"bibr69-WHE.12.50","DOI":"10.1016\/S0002-9343(99)80067-9"},{"doi-asserted-by":"publisher","key":"bibr70-WHE.12.50","DOI":"10.1093\/ajcn\/88.4.1149"},{"doi-asserted-by":"publisher","key":"bibr71-WHE.12.50","DOI":"10.3945\/ajcn.110.004671"},{"doi-asserted-by":"publisher","key":"bibr72-WHE.12.50","DOI":"10.1093\/ajcn\/75.2.275"},{"doi-asserted-by":"publisher","key":"bibr73-WHE.12.50","DOI":"10.1016\/j.contraception.2011.05.013"},{"doi-asserted-by":"publisher","key":"bibr74-WHE.12.50","DOI":"10.1093\/ajcn\/83.4.842"},{"doi-asserted-by":"publisher","key":"bibr75-WHE.12.50","DOI":"10.1038\/sj.ejcn.1602254"},{"doi-asserted-by":"publisher","key":"bibr76-WHE.12.50","DOI":"10.1007\/BF03256908"},{"key":"bibr77-WHE.12.50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14730782.2000.12288987","volume":"15","author":"Foidart JM","year":"2000","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"doi-asserted-by":"publisher","key":"bibr78-WHE.12.50","DOI":"10.1016\/S0010-7824(00)00083-4"},{"doi-asserted-by":"publisher","key":"bibr79-WHE.12.50","DOI":"10.1080\/13625180008500375"},{"doi-asserted-by":"publisher","key":"bibr80-WHE.12.50","DOI":"10.1016\/j.contraception.2008.12.007"},{"doi-asserted-by":"publisher","key":"bibr81-WHE.12.50","DOI":"10.1016\/j.ajog.2011.06.048"},{"issue":"2","key":"bibr82-WHE.12.50","first-page":"123","volume":"74","author":"Thorneycroft H","year":"2004","journal-title":"Cutis"},{"doi-asserted-by":"publisher","key":"bibr83-WHE.12.50","DOI":"10.1016\/j.jaad.2007.09.024"},{"key":"bibr84-WHE.12.50","first-page":"S2","volume":"69","author":"van Vloten WA","year":"2002","journal-title":"Cutis"},{"doi-asserted-by":"publisher","key":"bibr85-WHE.12.50","DOI":"10.2165\/11535450-000000000-00000"},{"doi-asserted-by":"publisher","key":"bibr86-WHE.12.50","DOI":"10.1016\/j.contraception.2010.02.009"},{"doi-asserted-by":"publisher","key":"bibr87-WHE.12.50","DOI":"10.1016\/j.contraception.2010.04.002"},{"doi-asserted-by":"publisher","key":"bibr88-WHE.12.50","DOI":"10.1007\/s00404-006-0280-6"},{"doi-asserted-by":"publisher","key":"bibr89-WHE.12.50","DOI":"10.1080\/ejc.8.1.37.51"},{"key":"bibr90-WHE.12.50","first-page":"S27","volume":"7","author":"Freeman EW","year":"2002","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"doi-asserted-by":"publisher","key":"bibr91-WHE.12.50","DOI":"10.1080\/13625180008500387"},{"doi-asserted-by":"publisher","key":"bibr92-WHE.12.50","DOI":"10.1111\/j.1549-8719.2011.00094.x"},{"doi-asserted-by":"publisher","key":"bibr93-WHE.12.50","DOI":"10.1016\/j.contraception.2010.03.009"},{"doi-asserted-by":"publisher","key":"bibr94-WHE.12.50","DOI":"10.1016\/j.fertnstert.2009.12.054"},{"unstructured":"A sharp reminder to depend on studies of relevant outcome rather than surrogate measures.","key":"bibr95-WHE.12.50"},{"doi-asserted-by":"publisher","key":"bibr96-WHE.12.50","DOI":"10.1016\/j.contraception.2006.12.019"},{"doi-asserted-by":"publisher","key":"bibr97-WHE.12.50","DOI":"10.1097\/01.AOG.0000279448.62221.a8"},{"doi-asserted-by":"publisher","key":"bibr98-WHE.12.50","DOI":"10.1136\/bmj.b2890"},{"doi-asserted-by":"publisher","key":"bibr99-WHE.12.50","DOI":"10.1136\/bmj.b2921"},{"doi-asserted-by":"publisher","key":"bibr100-WHE.12.50","DOI":"10.1136\/bmj.d2139"},{"doi-asserted-by":"publisher","key":"bibr101-WHE.12.50","DOI":"10.1136\/bmj.d2151"},{"doi-asserted-by":"publisher","key":"bibr102-WHE.12.50","DOI":"10.1136\/bmj.d6423"},{"doi-asserted-by":"publisher","key":"bibr103-WHE.12.50","DOI":"10.1503\/cmaj.110463"},{"doi-asserted-by":"publisher","key":"bibr104-WHE.12.50","DOI":"10.1097\/AOG.0b013e31825194ca"},{"unstructured":"Excellent and current commentary on available data about venous thromboembolism with combined hormonal contraceptives and the impact of focusing on this issue.","key":"bibr105-WHE.12.50"},{"unstructured":"EMA. Safyral. www.ema.europa.eu\/docs\/en_GB\/document_library\/Report\/2011\/05\/WC500106708.pdf (Accessed 23 October 2012).","key":"bibr106-WHE.12.50"},{"unstructured":"FDA Office of Surveillance and Epidemiology. Combined hormonal contraceptives (CHCs) and the risk of cardiovascular disease endpoints. www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM277384.pdf (Accessed 19 October 2012).","key":"bibr107-WHE.12.50"},{"unstructured":"Used as basis for labeling changes for many contraceptives in the short term.","key":"bibr108-WHE.12.50"},{"unstructured":"US FDA. Safyral label. www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/022574s004lbl.pdf (Accessed 23 October 2012).","key":"bibr109-WHE.12.50"},{"unstructured":"US Department of Health and Human Services. Healthy people 2020. www.healthypeople.gov (Accessed 19 October 2012).","key":"bibr110-WHE.12.50"}],"container-title":["Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.2217\/WHE.12.50","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.2217\/WHE.12.50","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.2217\/WHE.12.50","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T07:22:12Z","timestamp":1741677732000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.2217\/WHE.12.50"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":110,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["10.2217\/WHE.12.50"],"URL":"https:\/\/doi.org\/10.2217\/whe.12.50","relation":{},"ISSN":["1745-5057","1745-5065"],"issn-type":[{"type":"print","value":"1745-5057"},{"type":"electronic","value":"1745-5065"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}